Ascension Technology Corporation has been acquired by Roper Industries, Inc.
July 2012 — The private shareholders of Ascension Technology Corporation have sold all assets of the company to Roper Industries, Inc. for US$19 million.
Ascension Technology Corporation manufactures 3D magnetic tracking systems for image-guided navigation for minimal invasive surgery or diagnostic and therapeutic purposes. This allows for non-radiating navigation to the internal targets, such as tumors.
Roper Industries, Inc. designs, manufactures and distributes radio frequency products and services, industrial technology products, energy systems and controls, and medical and scientific imaging products and software.
Our role in the transaction
Oaklins' team in Dallas initiated this transaction, advised the seller and assisted in its closing. Oaklins' team in Japan was also involved in this transaction.
Talk to the deal team
Bryan Livingston
Oaklins Capital Alliance
Related deals
Comtax has been acquired by Ryan
Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreNextalia has acquired a majority stake in Witapp
Nextalia SGR S.p.A. has acquired a majority stake in Witapp S.r.l., an Italian company specializing in software development for the digitization of healthcare infrastructure. The acquisition strengthens Nextalia’s track record in technology companies serving the public sector and supports its strategy of investing in businesses operating at the intersection of healthcare digitization and the modernization of public services.
Learn more